STEM-Talk cover image

Episode 131: Christopher Logothetis discusses advances in prostate cancer therapies

STEM-Talk

CHAPTER

Prostate Cancer - What's on the Horizon?

Identifying the lethal subset of patients early on, so we can provide them specific, aggressive therapy and deal with the heterogenaty in that group. The other arm is to actually entify those patients where prostate cancers indicator of related events,. metabolic sindrome that are co associated with it. And you have to globally take care of them as a more holistic problem. So there's low hanging fruit in both of these domains to make an outcome. Does a great answer.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner